A Clinical Study to Evaluate the Safety and Tolerability of SCT-001 CAR-T Cells in Patients with Recurrent and Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Peritoneal Cancer.
NCT06846424 · NOT YET RECRUITING · Phase 1
We track 1 ClinicalTrials.gov studies led by Shanghai Gynecologic Oncology Group. The portfolio skews toward Phase 1 (1 trials).
1 clinical trials sponsored by Shanghai Gynecologic Oncology Group.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 1 | 100% |
Shanghai Gynecologic Oncology Group currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 1.
Shanghai Gynecologic Oncology Group conducts research across multiple therapeutic areas. Browse the trial listings for details.
Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.